Search

The natural occurrence of asbestos and asbestos-like minerals (NOA) poses a risk to the environment and human health, notably when natural processes and anthropic activities promote fibre dispersion. Hundreds of potentially hazardous elongate mineral particles (EMPs, NIOSH 2011 definition) exist, and their toxicological profile is often unknown. We aim here to define a general approach, from field analysis to nano-structural investigation, to assess whether a fibrous mineral occurring in a specific site could pose a risk to human health. To evaluate the hazard associated with NOA, a multi-scale and multi-analytical integrated approach was adopted. Specifically, the geological factors that control the occurrence and distribution of NOA on site, and the mechanisms of formation and liberation of airborne fibres were investigated. In parallel, we explored the key bulk and surface properties of several natural mineral fibres and defined crystallographic, chemical, and morphological aspects that should be considered during hazard assessment. Also, the effect of standardized mechanical stress was used to quantitatively evaluate the potency of NOA-bearing exposed rock to generate inhalable fibres. This property was connected with the mineral characteristic, the rock fabric, and the rock erosion rate. Isolated fibre specimens were used to assess solubility in simulated body fluids, surface reactivity, and toxicological endpoints in vitro and in vivo. Taken together, these findings allowed us to build a multidimensional description of the hazard parameters of mineral fibre and paved the way for a science-based risk assessment in an unexplored NOA site.

The current paradigm for explaining lung granulomatous diseases induced by inhaled particles is mainly based on macrophages. This mechanism is now challenging because B lymphocytes also infiltrate injured tissue, and the deficiency in B lymphocytes is associated with limited lung granulomas in silica-treated mice. Here, we investigated how B lymphocytes respond to micro- and nanoparticles by combining in vivo and in vitro mouse models. We first demonstrated that innate-like B-1 lymphocytes (not conventional B-2 lymphocytes or plasma cells) specifically accumulated during granuloma formation in mice instilled with crystalline silica (DQ12, 2.5 mg/mouse) and carbon nanotubes (CNT Mitsui, 0.2 mg/mouse). In comparison to macrophages, peritoneal B-1 lymphocytes purified from naïve mice were resistant to the pyroptotic activity of reactive particles (up to 1 mg/mL) but clustered to establish in vitro cell/particle aggregates. Mouse B-1 lymphocytes (not B-2 lymphocytes) in coculture with macrophages and CNT (0.1 µg/mL) organized three-dimensional spheroid structures in Matrigel and stimulated the release of TIMP-1. Furthermore, purified B-1 lymphocytes are sensitive to nanosilica toxicity through radical generation in culture. Nanosilica-exposed B-1 lymphocytes released proinflammatory cytokines and alarmins. In conclusion, our data indicate that in addition to macrophages, B-1 lymphocytes participate in micrometric particle-induced granuloma formation and display inflammatory functions in response to nanoparticles.

Although epidemiological studies have suggested an association between asbestos exposure and systemic autoimmunity, the underlying mechanisms are poorly understood. Short asbestos fibers are often considered less harmful than long fibers but such a statement is still a matter of debates. This study aimed to compare the effects of short (SFA) and long (LFA) amosite fiber exposure on lung damage, autoimmunity and macrophage phenotype. Four months after lung exposure to 0.1 mg of fibers, BAL levels of lactate dehydrogenase, free DNA, CCL2, TIMP-1 and immunoglobulins A of LFA-exposed C57Bl/6 mice were increased when compared to fluids from control- and SFA-exposed mice. Effects in LFA-exposed mice were associated with lung fibrosis and autoimmunity including anti-double-strand DNA antibody production. Human monocyte-derived macrophages (MDMs) exposed to SFA or LFA at 20 µg/cm2 have a pro-inflammatory phenotype characterized by a significant increase of TNFα and IL-6 secretion. A decrease of efferocytosis capacities was also noted after SFA and LFA, whereas macrophage abilities to phagocyte fluorescent beads were unchanged when compared to control MDMs. SFA exposure induced IL-6 secretion and reduced the percentage of MDMs expressing MHCII and CD86 markers involved in antigen and T-lymphocyte stimulation. By contrast, NLRP3 inflammasome activation, evaluated through quantification of caspase-1 activity and IL-1β secretion is rather associated to LFA than SFA exposure. Our results demonstrated that only long-term exposure to LFA has induced significant lung damages and autoimmune effects supporting a worsened health effects of LFA in comparison to SFA.

IL-1α is an intracellular danger signal (DAMP) released by macrophages contributing to the development of silica-induced lung inflammation. The exact molecular mechanism orchestrating IL-1α extracellular release from particle-exposed macrophages is still unclear. To delineate this process, murine J774 and bone-marrow derived macrophages were exposed to increasing concentrations (1–40 cm2/ml) of a set of amorphous and crystalline silica particles with different surface chemical features. In particular, these characteristics include the content of nearly free silanols (NFS), a silanol population responsible for silica cytotoxicity recently identified. We first observed de novo stocks of IL-1α in macrophages after silica internalization regardless of particle physico-chemical characteristics and cell stress. IL-1α intracellular production and accumulation were observed by exposing macrophages to biologically-inert or cytotoxic crystalline and amorphous silicas. In contrast, only NFS-rich reactive silica particles triggered IL-1α release into the extracellular milieu from necrotic macrophages. We demonstrate that IL-1α is actively secreted through the formation of gasdermin D (GSDMD) pores in the plasma membrane and not passively released after macrophage plasma membrane lysis. Our findings indicate that the GSDMD pore-dependent secretion of IL-1α stock from macrophages solely depends on cytotoxicity induced by NFS-rich silica. This new regulated process represents a key first event in the mechanism of silica toxicity, suitable to refine the existing adverse outcome pathway (AOP) for predicting the inflammatory activity of silicas.

Pulmonary hypertension (PH) is a chronic disorder of the pulmonary circulation that often associates with other respiratory diseases (i.e., group III PH), leading to worsened symptoms and prognosis, notably when combined with interstitial lung diseases such as pulmonary fibrosis (PF). PH may lead to right ventricular (RV) failure, which accounts for a substantial part of the mortality in chronic lung disease patients. The disappointing results of pulmonary arterial hypertension (PAH)-related therapies in patients with PF emphasize the need to better understand the pathophysiologic mechanisms that drive PH development and progression in this specific setting. In this work, we validated an animal model of group III PH associated with PF (PH-PF), by using bleomycin (BM) intratracheal instillation and characterizing the nature of induced lung and vascular remodeling, including the influence on RV structure and function. To our knowledge, this is the first work describing this dose of BM in Sprague Dawley rats and the effects upon the heart and lungs, using different techniques such as echocardiography, heart catheterization, and histology. Our data shows the successful implementation of a rat model that mimics combined PF-PH, with most features seen in the equivalent human disease, such as lung and arterial remodeling, increased mPAP and RV dysfunction. ispartof: PULMONARY CIRCULATION vol:13 issue:1 ispartof: location:United States status: published

Papillary thyroid carcinoma (PTC) is the most frequent histological subtype of thyroid cancers (TC), and BRAFV600E genetic alteration is found in 60% of this endocrine cancer. This oncogene is associated with poor prognosis, resistance to radioiodine therapy, and tumor progression. Histological follow-up by anatomo-pathologists revealed that two-thirds of surgically-removed thyroids do not present malignant lesions. Thus, continued fundamental research into the molecular mechanisms of TC downstream of BRAFV600E remains central to better understanding the clinical behavior of these tumors. To study PTC, we used a mouse model in which expression of BRAFV600E was specifically switched on in thyrocytes by doxycycline administration. Upon daily intraperitoneal doxycycline injection, thyroid tissue rapidly acquired histological features mimicking human PTC. Transcriptomic analysis revealed major changes in immune signaling pathways upon BRAFV600E induction. Multiplex immunofluorescence confirmed the abundant recruitment of macrophages, among which a population of LYVE-1+/CD206+/STABILIN-1+ was dramatically increased. By genetically inactivating the gene coding for the scavenger receptor STABILIN-1, we showed an increase of CD8+ T cells in this in situ BRAFV600E-dependent TC. Lastly, we demonstrated the presence of CD206+/STABILIN-1+ macrophages in human thyroid pathologies. Altogether, we revealed the recruitment of immunosuppressive STABILIN-1 macrophages in a PTC mouse model and the interest to further study this macrophage subpopulation in human thyroid tissues.

Papillary thyroid carcinoma (PTC) is the most frequent histological subtype of thyroid cancers (TC), and BRAF

Exposure to asbestos is known for inducing inflammation, pulmonary fibrosis, lung cancer and malignant mesothelioma. Although several novel biomarkers and treatments are being tested, these chronic disorders are currently incurable, and the prognosis is particularly poor. The development of asbestos-induced cancer results from mutations, cell transformation and proliferation caused by reactive oxygen species and elevated levels of pro-inflammatory cytokines. Fiber-induced chronic inflammation also explains asbestosis, an interstitial lung disease characterized by uncontrolled matrix protein deposition leading to detrimental lung fibrosis. The investigation of the in-vivo molecular mechanisms driving asbestos pathogenicity is still a matter of debate. In this context, it is accepted that the physico-chemical properties of the fibers play a crucial role in causing adverse effects, and long fibers are still considered more toxic than short ones. Indeed, when fibers reach the alveolar space and migrate to the pleural/peritoneal cavity, long and thin fibers shows stronger inflammogenic, fibrogenic and tumorigenic effects than short fibers, in the long term. It is largely hold that short asbestos fibers are more easily cleared from the lungs and elicit a lower reactional and/or inflammatory effect. To further investigate this paradigm of toxicity, we compared the pro-inflammatory and pro-fibrogenic potential of short and long amosite fibers in in-vitro (J774 murine macrophages) and in-vivo (C57BL/6 mice) models. Surprisingly, our results demonstrated that short fibers were more prone to induce in-vitro cytotoxicity, accompanied by the release of pro-inflammatory biomarkers, in comparison to long fibers. On the contrary, the long fibers were significantly more inflammogenic and fibrogenic in the lungs of treated mice, while the short fibers were almost inert and did not induce acute and chronic inflammation and fibrosis. Furthermore, we observed that, while the long fibers were still present in the lungs of the animals 4 months after the exposure, the short amosite was substantially absent. These findings imply that the pulmonary deposition and a defect of clearance of the fibers play a crucial role in the development of in-vivo detrimental effects associated to long asbestos. This effect overcomes the mere in-vitro cytotoxic and inflammogenic potential of short fibers. Present results provide new insights into the mechanisms that drive asbestos toxicity, opening new perspectives for the development of reliable in vitro tests that fully predict health adverse effects associated to inorganic mineral fibers.

Pulmonary fibrosis (PF) and pulmonary hypertension (PH) are chronic diseases of the pulmonary parenchyma and circulation, respectively, which may coexist, but underlying mechanisms remain elusive. Mutations in the GCN2 gene (EIF2AK4) were recently associated with pulmonary veno-occlusive disease. This study aims to explore the involvement of the GCN2/eIF2α pathway in the development of PH during PF, in both human disease and in an experimental animal model. Lung tissue from PF patients with or without PH were collected at the time of lung transplantation, and controls were obtained from tumor resection surgery. Experimental lung disease was induced in either male wild-type or EIF2AK4-mutated Sprague-Dawley rats, randomly receiving a single intratracheal instillation of bleomycin or saline. Hemodynamic studies, as well as organ collection were performed 3 weeks post-instillation. Only significant results (p

Cystic fibrosis is associated with chronic Pseudomonas aeruginosa colonization and inflammation. The role of MyD88, the shared adapter protein of the proinflammatory TLR and IL-1R families, in chronic P. aeruginosa biofilm lung infection is unknown. We report that chronic lung infection with the clinical P. aeruginosa RP73 strain is associated with uncontrolled lung infection in complete MyD88-deficient mice with epithelial damage, inflammation, and rapid death. Then, we investigated whether alveolar or myeloid cells contribute to heightened sensitivity to infection. Using cell-specific, MyD88-deficient mice, we uncover that the MyD88 pathway in myeloid or alveolar epithelial cells is dispensable, suggesting that other cell types may control the high sensitivity of MyD88-deficient mice. By contrast, IL-1R1–deficient mice control chronic P. aeruginosa RP73 infection and IL-1β Ab blockade did not reduce host resistance. Therefore, the IL-1R1/MyD88 pathway is not involved, but other IL-1R or TLR family members need to be investigated. Our data strongly suggest that IL-1 targeted neutralizing therapies used to treat inflammatory diseases in patients unlikely reduce host resistance to chronic P. aeruginosa infection.

Background: GCN2, a major stress regulator, was recently implicated in pulmonary veno-occlusive disease (Eyries M, et al. Nat Genet 2014 and Perros F, et al. Circulation 2015). This study aims to explore the involvement of the GCN2/eIF2α signalling pathway in the development of pulmonary hypertension (PH) during idiopathic pulmonary fibrosis (IPF), in both human disease and in an experimental animal model. Methods: Lung tissue from IPF patients (n=19) with or w/o PH were collected at the time of lung transplantation, and controls (CTR, n=11) were obtained from tumour resection surgery. Experimental lung disease was induced in male SD rats, randomly receiving a single intratracheal instillation of bleomycin (BM, 7.5U/Kg) or saline (SL). Echocardiographic and haemodynamic studies, as well as organ collection were performed 3 weeks post-instillation. Only significant results (p Results: In total IPF lung tissue, GCN2 protein expression was decreased, when compared with CTR. GCN2 expression was reduced in CD31-positive endothelial cells, regardless the presence of PH. Rats treated with BM showed increased parenchymal fibrosis (hydroxyproline levels) and vascular remodelling (media wall thickness) as well as increased mean pulmonary artery pressure and impaired right ventricular function. In line with human data, GCN2 protein expression was decreased in the lung of BM rats when compared with SL. Conclusion: Our data show that GCN2 is dysregulated in both human IPF and in an animal model of combined IPF+PH. The possibility of a causative implication of GCN2 dysregulation in IPF and/or PH development will be further studied.

Monocytes infiltrating scar tissue are predominantly viewed as progenitor cells. Here, we show that tissue CCR2+ monocytes have specific immunosuppressive and profibrotic functions. CCR2+ monocytic cells are acutely recruited to the lung before the onset of silica-induced fibrosis in mice. These tissue monocytes are defined as monocytic myeloid-derived suppressor cells (M-MDSCs) because they significantly suppress T-lymphocyte proliferation in vitro. M-MDSCs collected from silica-treated mice also express transforming growth factor (TGF)-β1, which stimulates lung fibroblasts to release tissue inhibitor of metalloproteinase (TIMP)-1, an inhibitor of metalloproteinase collagenolytic activity. By using LysMCreCCR2loxP/loxP mice, we show that limiting CCR2+ M-MDSC accumulation reduces the pulmonary contents of TGF-β1, TIMP-1 and collagen after silica treatment. M-MDSCs do not differentiate into lung macrophages, granulocytes or fibrocytes during pulmonary fibrogenesis. Collectively, our data indicate that M-MDSCs contribute to lung fibrosis by specifically promoting a non-degrading collagen microenvironment. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Background In workers exposed mostly to laboratory animals (LA), symptoms may be due to irritants or allergens. Correct aetiological diagnosis is important for health surveillance. Objectives This study aims to test whether work-related (WR) allergen-induced symptoms are associated with a cytokine profile distinct from that due to irritants. Methods In a cross-sectional study (n=114), WR respiratory and/or skin symptoms were assessed through a standardised clinical examination and sensitisation to rat and/or mouse allergen determined by serum immunoglobulin E. Serum cytokine concentrations were measured by multiplex assays. The predefined cytokine profiles ‘sensitiser’ (interleukin (IL)-4, IL-5, IL-13, eotaxin-1) and ‘irritation’ (IL-8, IL-17A, IL-17F, IL-22) were considered positive, when ≥3 concentrations exceeded the 95th percentile of the asymptomatic non-sensitised group. Results were examined by hierarchical clustering analyses (HCA) and multiple linear regression. Explorative analyses were carried out for nine additional cytokines. Exposure to allergens and endotoxin was assessed in a subpopulation. Results The prevalence of the profile ‘irritation’ was comparable in 28 symptomatic non-sensitised workers and 71 asymptomatic non-sensitised workers. HCA showed that nearly all symptomatic non-sensitised workers were gathered in two subclusters, characterised by high IL-17A levels, but different IL-8 levels. Multiple linear regression identified drug consumption and current complaints as confounders. Sensitised subjects were too few (n=14) for testing the profile ‘sensitiser’. Conclusions In this unselected population of LA workers, the profile ‘irritation’ did not prove to be a valuable health surveillance tool. Low power precluded assessment of the profile ‘sensitiser’. The increased IL-17A concentration may originate from irritative constituents of organic dust.

Brains of Alzheimer’s disease patients are characterized by the presence of amyloid plaques and neurofbrillary tangles, both invariably associated with neuroinfammation. A crucial role for NLRP3–ASC infammasome [NACHT, LRR and PYD domains-containing protein 3 (NLRP3)–Apoptosis-associated speck-like protein containing a CARD (ASC)] in amyloid-beta (Aβ)-induced microgliosis and Aβ pathology has been unequivocally identifed. Aβ aggregates activate NLRP3–ASC infammasome (Halle et al. in Nat Immunol 9:857–865, 2008) and conversely NLRP3–ASC infammasome activation exacerbates amyloid pathology in vivo (Heneka et al. in Nature 493:674–678, 2013), including by prion-like ASC-speck cross-seeding (Venegas et al. in Nature 552:355–361, 2017). However, the link between infammasome activation, as crucial sensor of innate immunity, and Tau remains unexplored. Here, we analyzed whether Tau aggregates acting as prion-like Tau seeds can activate NLRP3–ASC infammasome. We demonstrate that Tau seeds activate NLRP3–ASC-dependent infammasome in primary microglia, following microglial uptake and lysosomal sorting of Tau seeds. Next, we analyzed the role of infammasome activation in prion-like or templated seeding of Tau pathology and found signifcant inhibition of exogenously seeded Tau pathology by ASC defciency in Tau transgenic mice. We furthermore demonstrate that chronic intracerebral administration of the NLRP3 inhibitor, MCC950, inhibits exogenously seeded Tau pathology. Finally, ASC defciency also decreased nonexogenously seeded Tau pathology in Tau transgenic mice. Overall our fndings demonstrate that Tau-seeding competent, aggregated Tau activates the ASC infammasome through the NLRP3–ASC axis, and we demonstrate an exacerbating role of the NLRP3–ASC axis on exogenously and non-exogenously seeded Tau pathology in Tau mice in vivo. The NLRP3–ASC infammasome, which is an important sensor of innate immunity and intensively explored for its role in health and disease, hence presents as an interesting therapeutic approach to target three crucial pathogenetic processes in AD, including prionlike seeding of Tau pathology, Aβ pathology and neuroinfammation. This work was supported by the Belgian Fonds National pour la Recherche Scientifque–Fonds de la Recherche Scientifque (FNRS-FRS; Qualifed Researcher—IDW), VLAIO (Vlaams Agentschap Innoveren en Ondernemen), FWO (Fonds Wetenschappelijk Onderzoek—Vlaanderen—G0C6819N) and FRA-SAO (Fondation Recherche Alzheimer—Stichting Alzheimer Onderzoek, Belgium).

Background: Idiopathic pulmonary fibrosis (IPF) is characterized by a progressive and irreversible respiratory failure. Non-invasive markers of disease activity are essential for prognosis and evaluation of early response to anti-fibrotic treatments. Objectives: The aims of this study were to determine whether fluorodeoxyglucose ([18F]-FDG) lung uptake is reduced after initiation of pirfenidone or nintedanib and to assess its possible use as a prognostic factor. Methods: [18F]-FDG PET/CT was performed in IPF patients and in a murine model of pulmonary fibrosis. PET/CTs were performed at day 8 and day 15 post-instillation of bleomycin in pirfenidone- or vehicule-treated mice. In IPF patients, PET-CT was performed before and 3 months after the initiation of pirfenidone or nintedanib. Results: In bleomycin-treated mice, pirfenidone significantly reduced the [18F]-FDG uptake compared to vehicule-treated mice at day 15 (p < 0.001), whereas no difference was observed at day 8 after bleomycin administration. In IPF patients, [18F]-FDG lung uptake before and after 3 months of treatment by nintedanib (n = 11) or pirfenidone (n = 14) showed no significant difference regardless the antifibrotic treatment. Moreover, no difference was noticed between patients with progressive or non-progressive disease at one year of follow up. Conclusions: Pirfenidone significantly reduces the lung [18F]-FDG uptake during the fibrotic phase in a mouse model of IPF. However, these preclinical data were not confirmed in IPF patients 3 months after the initiation of antifibrotic therapy. [18F]-FDG seems therefore not useful in clinical practice to assess the early response of IPF patients to nintedanib or pirfenidone., SCOPUS: ar.j, info:eu-repo/semantics/published

The purpose of this study was to assess whether cationic nanoliposomes could address tumor vaccines to dendritic cells in the lungs in vivo. Nanoliposomes were prepared using a cationic lipid, dimethylaminoethanecarbamoyl-cholesterol (DC-cholesterol) or dioleoyltrimethylammoniumpropane (DOTAP), and dipalmitoylphosphatidylcholine (DPPC), the most abundant phospholipid in lung surfactant. The liposomes presented a size below 175 nm and they effectively entrapped tumor antigens, an oligodeoxynucletotide containing CpG motifs (CpG) and the fluorescent dye calcein used as a tracer. Although the liposomes could permanently entrap a large fraction of the actives, they could not sustain their release in vitro. Liposomes made of DOTAP were safe to respiratory cells in vitro, while liposomes composed of DC-cholesterol were cytotoxic. DOTAP nanoliposomes were mainly taken up by alveolar macrophages following delivery to the lungs in mice. Few dendritic cells took up the liposomes, and interstitial macrophages did not take up liposomal calcein more than they took up soluble calcein. Stimulation of the innate immune system using liposomal CpG strongly enhanced uptake of calcein liposomes by all phagocytes in the lungs. Although a small percentage of dendritic cells took up the nanoliposomes, alveolar macrophages represented a major barrier to dendritic cell access in the lungs.

Experimental lung fibrogenic injury was induced in male Sprague-Dawley rats, randomly receiving a single intratracheal instillation of bleomycin sulphate (B, 7.5U/Kg) or saline (S). Echocardiographic and haemodynamic studies, as well as bronchoalveolar lavage fluid (BALF), blood and organ collection were performed 3 weeks after B instillation. Biochemical and histological studies confirmed the development of fibrosis in B-treated lungs, as shown by the increase in hydroxyproline content, as well as an increase in Sirius red stained areas both in proximal and distal lung tissue. Interestingly, in addition to parenchymal fibrosis, echocardiographic and haemodynamic studies revealed that B group developed mild PH, as shown by increased right ventricular end-systolic pressure (RVESP), mean pulmonary artery pressure (mPAP) and total pulmonary vascular resistance (TPVR). There were also indices of compromised right ventricular function, with decreased cardiac output (CO) and tricuspid annular plane systolic excursion (TAPSE). Moreover, rats submitted to B presented RV hypertrophy as shown by the Fulton Index. In addition and confirming PH development in these animals, vascular remodelling was observed in the B group, as shown by the increase in the arterial wall area. Our data shows the successful implementation of a rodent model that mimics combined lung (parenchymal) fibrosis and PH, with most of the features seen in human, such as lung and arterial remodelling, increased mPAP and compromised RV function, allowing future research to be focused on pathological mechanisms and possible new therapeutic targets.

Introduction: Epithelial dysfunction, including bronchiolization and type 2 alveolar cells (AEC2) hyperplasia, is a hallmark of idiopathic pulmonary fibrosis (IPF). A recent study linked IgA level to IPF prognosis. Therefore, we investigated the involvement of the polymeric immunoglobulin receptor (pIgR), the IgA transporter across epithelium, in IPF. Methods: Surgical lung samples from IPF patients and control subjects were immunostained for pIgR and pro-SPC (AEC2). In vivo experiments were performed in a recent model of chronic fibrosis that closely recapitulates IPF: 12 weeks-old C57/B6 pIgR-/- mice, as compared to littermate controls (WT), were treated with 6 successive instillations of 0.015 IU of bleomycin (BLM) or control NaCl every 12 days (d1-60). Broncho-alveolar lavage was harvested for cell counting and lung sections were stained by HE, Sirius Red and Masson’s trichrome at day 95. Lung fibrosis was quantitatively assessed by the modified Ashcroft score and OH-proline assay (µg/lobe). Results: Immunostaining of human IPF lungs revealed an ectopic expression of pIgR in IPF but not in control lungs, within AEC2 clusters. These findings were confirmed in lungs from BLM-treated mice. In addition, pIgR-/- mice displayed significantly less fibrosis as compared to control mice (96.27±30.55 vs 133.70±19.46, mean ± SD OH-proline µg/lobe, p=0.01), which correlated with histologic findings. There was no significant difference regarding inflammatory cell counts in BAL. Discussion Our preliminary data indicate an involvement of the pIgR axis in lung fibrosis, supporting the role of aberrant pIgR expression in IPF pathogenesis. Next steps will include studies of a cohort of IPF patients and of the underlying mechanisms

Major progress has been achieved in recent years to elucidate mechanisms driving the early response of pulmonary innate immune cells to inhaled micrometric and nanometric particles. Mononuclear phagocytes promptly categorize particles, alert immune network and engage crescendo responses for particle clearance and homeostasis restoration. Negatively charged particles directly interact with scavenger receptors A and B (SR-A and SR-B) and consequently activate specific signaling pathways, resulting in the production of TNF and IL-1 family members, which coordinate effective innate immune responses. Cytokine secretion also arises after a simple contact between particle-associated radicals and cell membranes. Reactive particles engage the passive release of constitutive alarmins, ensuing particle- or TNF-α-induced cell death and membranolysis. Finally, the inflammasome machinery represents the decisive intracellular platform that finely tune immune pathways engaged after SR activation, alarmin release, TNF-α production and cell homeostasis perturbations. Disturbance of these collective recognition processes prolongs particle persistence and innate immune responses that generate long-lasting adaptive immunity and cause chronic lung diseases.

Occupational exposure to indium tin oxide (ITO) particles has been associated with the development of severe lung diseases, including pulmonary alveolar proteinosis (PAP). The mechanisms of this lung toxicity remain unknown. Here, we reveal the respective roles of resident alveolar (Siglec-Fhigh AM) and recruited interstitial (Siglec-Flow IM) macrophages contributing in concert to the development of PAP. In mice treated with ITO particles, PAP is specifically associated with IL-1α (not GM-CSF) deficiency and Siglec-Fhigh AM (not Siglec-Flow IM) depletion. Mechanistically, ITO particles are preferentially phagocytosed and dissolved to soluble In3+ by Siglec-Flow IM. In contrast, Siglec-Fhigh AM weakly phagocytose or dissolve ITO particles, but are sensitive to released In3+ through the expression of the transferrin receptor-1 (TfR1). Blocking pulmonary Siglec-Flow IM recruitment in CCR2-deficient mice reduces ITO particle dissolution, In3+ release, Siglec-Fhigh AM depletion, and PAP formation. Restoration of IL-1-related Siglec-Fhigh AM also prevented ITO-induced PAP. We identified a new mechanism of secondary PAP development according to which metal ions released from inhaled particles by phagocytic IM disturb IL-1α-dependent AM self-maintenance and, in turn, alveolar clearance.

Exposure to conidia of Aspergillus fumigatus was described as a causative factor of a number of the respiratory system diseases, including asthma, chronic eosinophilic pneumonia, hypersensitivity pneumonitis and bronchopulmonary aspergillosis. The study investigates the effects of the repeated exposure to A. fumigatus in mice pulmonary compartment. Our work tackles two, so far insufficiently addressed, important aspects of interaction between affected organism and A. fumigatus: 1) recurrent character of exposure (characteristic for pathomechanism of the abovementioned disease states) and 2) impact of aging, potentially important for the differentiation response to an antigen.

In laboratory animal work, allergens are classically considered to play a prominent role in generation of respiratory and skin symptoms. However, recent development may have changed working conditions and require an updating of preventive measures. In workers exposed to a range of animals besides laboratory mice and rats the relative role of endotoxin, irritants, and allergens in symptom generation was assessed for updating preventative measures and health surveillance. Eligible workers were recruited from university units in which exposure to rats and/or mice, occurrence of respiratory and/or skin symptoms, and/or a history of animal bites had been reported. Exposure to endotoxin and rat and mouse allergen was assessed (71 half-day personal samples). 'Symptomatic' was defined by work-related ocular, nasal, respiratory, or skin symptoms. A concentration of specific IgE against rat or mouse (e87 and e88) ≥0.35 kU/l defined sensitization. Sensitivity analyses examined the effect of alternative exposure indicators and definitions of 'sensitized' and 'symptomatic'. From 302 eligible workers, 177 participated. There were 121 and 41 workers in the asymptomatic and non-sensitized and symptomatic but non-sensitized group, respectively. Eight subjects were symptomatic and sensitized. Six sensitized subjects were asymptomatic. One participant could not be assigned to a subgroup. Airborne endotoxin and allergen concentrations were mostly below 20 EU m-3 or the detection limit, respectively. Clinical history showed that irritants and sensitizers other than mouse/rat allergen or endotoxin were a major cause of symptoms. Results were sensitive to the selected exposure indicator and the definition of 'symptomatic'. Health surveillance programs need to be adapted to include a larger range of allergens and pay more attention to irritants.

Bacterial peritonitis remains the main cause of technique failure in peritoneal dialysis (PD). During peritonitis, the peritoneal membrane undergoes structural and functional alterations that are mediated by IL-1β. The NLRP3 inflammasome is a caspase-1–activating multiprotein complex that links sensing of microbial and stress products to activation of proinflammatory cytokines, including IL-1β. The potential roles of the NLRP3 inflammasome and IL-1β in the peritoneal membrane during acute peritonitis have not been investigated. Here, we show that the NLRP3 inflammasome is activated during acute bacterial peritonitis in patients on PD, and this activation associates with the release of IL-1β in the dialysate. In mice, lipopolysaccharide- or Escherichia coli-induced peritonitis led to IL-1β release in the peritoneal membrane. The genetic deletion of Nalp3, which encodes NLRP3, abrogated defects in solute transport during acute peritonitis and restored ultrafiltration. In human umbilical vein endothelial cells, IL-1β treatment directly enhanced endothelial cell proliferation and increased microvascular permeability. These in vitro effects require endothelial IL-1 receptors, shown by immunofluorescence to be expressed in peritoneal capillaries in mice. Furthermore, administration of the IL-1β receptor antagonist, anakinra, efficiently decreased nitric oxide production and vascular proliferation and restored peritoneal function in mouse models of peritonitis, even in mice treated with standard-of-care antibiotherapy. These data demonstrate that NLRP3 activation and IL-1β release have a critical role in solute transport defects and tissue remodeling during PD-related peritonitis. Blockade of the NLRP3/IL-1β axis offers a novel method for rescuing morphologic alterations and transport defects during acute peritonitis.

Monocytes infiltrating scar tissue are predominantly viewed as progenitor cells. Here, we show that tissue CCR2

Glufosinate-ammonium (GLA), the active component of an herbicide, is known to cause neurotoxicity. GLA shares structural analogy with glutamate. It is a powerful inhibitor of glutamine synthetase (GS) and may bind to glutamate receptors. Since these potentials targets of GLA are present in lung and immune cells, we asked whether airway exposure to GLA may cause lung inflammation in mice. A single GLA exposure (1 mg/kg) induced seizures and inflammatory cell recruitment in the broncho-alveolar space, and increased myeloperoxidase (MPO), inducible NO synthase (iNOS), interstitial inflammation and disruption of alveolar septae within 6–24 h. Interleukin 1β (IL-1β) was increased and lung inflammation depended on IL-1 receptor 1 (IL-1R1). We demonstrate that glutamate receptor pathway is central, since the N-methyl-D-aspartate (NMDA) receptor inhibitor MK-801 prevented GLA-induced lung inflammation. Chronic exposure (0.2 mg/kg 3× per week for 4 weeks) caused moderate lung inflammation and enhanced airway hyperreactivity with significant increased airway resistance. In conclusion, GLA aerosol exposure causes glutamate signalling and IL-1R-dependent pulmonary inflammation with airway hyperreactivity in mice.

Background The asbestos-like toxicity of some engineered carbon nanotubes (CNT), notably their capacity to induce mesothelioma, is a serious cause of concern for public health. Here we show that carcinogenic CNT induce an early and sustained immunosuppressive response characterized by the accumulation of monocytic Myeloid Derived Suppressor Cells (M-MDSC) that counteract effective immune surveillance of tumor cells. Methods Wistar rats and C57BL/6 mice were intraperitoneally injected with carcinogenic multi-walled Mitsui-7 CNT (CNT-7) or crocidolite asbestos. Peritoneal mesothelioma development and immune cell accumulation were assessed until 12 months. Leukocyte sub-populations were identified by recording expression of CD11b/c and His48 by flow cytometry. The immunosuppressive activity on T lymphocytes of purified peritoneal leukocytes was assessed in a co-culture assay with activated spleen cells. Results We demonstrate that long and short mesotheliomagenic CNT-7 injected in the peritoneal cavity of rats induced, like asbestos, an early and selective accumulation of monocytic cells (CD11b/cint and His48hi) which possess the ability to suppress polyclonal activation of T lymphocytes and correspond to M-MDSC. Peritoneal M-MDSC persisted during the development of peritoneal mesothelioma in CNT-7-treated rats but were only transiently recruited after non-carcinogenic CNT (CNT-M, CNT-T) injection. Peritoneal M-MDSC did not accumulate in mice which are resistant to mesothelioma development. Conclusions Our data provide new insights into the initial pathogenic events induced by CNT, adding a new component to the adverse outcome pathway leading to mesothelioma development. The specificity of the M-MDSC response after carcinogenic CNT exposure highlights the interest of this response for detecting the ability of new nanomaterials to cause cancer. Electronic supplementary material The online version of this article (doi:10.1186/s12989-016-0158-0) contains supplementary material, which is available to authorized users.

The innate immune system is the first line of defense against inhaled particles. Macrophages serve important roles in particle clearance and inflammatory reactions. Following recognition and internalization by phagocytes, particles are taken up in vesicular phagolysosomes. Intracellular phagosomal leakage, redox unbalance and ionic movements induced by toxic particles result in pro-IL-1β expression, inflammasome complex engagement, caspase-1 activation, pro-IL-1β cleavage, biologically-active IL-1β release and finally inflammatory cell death termed pyroptosis. In this review, we summarize the emerging signals and pathways involved in the expression, maturation and secretion of IL-1β during these responses to particles. We also highlight physicochemical characteristics of particles (size, surface and shape) which determine their capacity to induce inflammasome activation and IL-1β processing.

Objectives: Having recently demonstrated that vardenafil, a phosphodiesterase type 5 inhibitor, reduces LPS-induced inflammatory responses in CF mice, we hypothesized that CF macrophages are characterized by a pro-inflammatory phenotype which can be modulated by vardenafil. We also want to study the role of CFTR in this vardenafil-induced immunomodulation of macrophages. Methods: Macrophages were purified from lung homogenates from homozygous F508del-CFTR, CFTR-/- (KO) and wild-type (WT) mice. To test the hypothesis that macrophages activity is altered in F508del-CF and KO mice, macrophages differentiation in pro-inflammatory (M1) effectors was studied after polarization with LPS and IFN-γ. Pro-inflammatory mediators TNF-α and NOS-2 were quantified by ELISA or by quantitative RT-PCR. Results: F508del-CF lung macrophages displayed an exaggerated pro-inflammatory response to M1 mediators. Both TNF-α and NOS-2 levels were more than doubled. Similar observations were made in macrophages isolated from KO mice, confirming that loss of CFTR promotes pro-inflammatory phenotype in macrophages. In F508del-CF mice, vardenafil reduced the expression of pro-inflammatory mediators by at least 50%. However, vardenafil failed to normalize TNF-α and NOS-2 expression in KO macrophages, suggesting that the presence of CFTR protein is required for immunomodulation by vardenafil. Conclusion: Taken together, our results indicate that macrophages display a pro-inflammatory profile and play a critical role in inflammatory responses in CF. Moreover, the immunomodulatory effect of vardenafil, which could thus be beneficial in CF pharmacotherapy, requires CFTR expression.